Pneumonia in the patient with chronic obstructive pulmonary disease.: Levels of severity and risk classification

被引:0
|
作者
de Oña, JMR
Fernández, MG
Celdrán, J
Puente-Maestu, L
机构
[1] Hosp Nuestra Senora Prado, Unidad Gest Clin Neumol, Talavera De La Reina, Toledo, Spain
[2] Univ Madrid, Hosp Gen Gregorio Maranon, Serv Neumol, Madrid 3, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2003年 / 39卷 / 03期
关键词
pneumonia; risk; COPD;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OBJECTIVES: To analyze the severity, clinical course and mortality in patients with community-acquired pneumonia and COPD. METHOD: Retrospective study of patients admitted with pneumonia over a period of 12 months. From records, we gathered information related to patient characteristics, signs and symptoms and concomitant disease and classified each patient according to risk. RESULTS: One hundred twenty-nine patients with a mean age of 71.13 (SD 17) were identified; 43 (33.3%) had COPD with severe airflow obstruction (FEV1 937 mL, SD 309), although there were no differences from one risk classification to another. No significant differences were found in mortality, as 8 patients (18.6%) with COPD died and 9 patients (10.7%) without COPD. The length of hospital stay was similar in both groups. Patients with COPD suffered more severe pneumonia and were at higher risk (classes IV and V). The percentage of COPD patients using chronic domiciliary oxygen therapy who died (75%) was different from the percentage of such patients who lived (37%); percent mortality also differed by level of risk. Patients receiving oxygen therapy had greater obstruction and greater respiratory insufficiency upon admission (PaO2/FiO(2): 216.9, SID 41.92). CONCLUSIONS: The mortality rates and mean hospital stays of patients with and without COPD who are admitted with community-acquired pneumonia are similar, but patients with COPD suffer more severe pneumonia. Mortality is higher in patients with community-acquired pneumonia and COPD who are receiving domiciliary oxygen therapy and have greater airflow obstruction and respiratory deterioration upon admission.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 50 条
  • [41] Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis
    Hartley, Benjamin F.
    Barnes, Neil C.
    Lettis, Sally
    Compton, Chris H.
    Papi, Alberto
    Jones, Paul
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [42] Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis
    Benjamin F. Hartley
    Neil C. Barnes
    Sally Lettis
    Chris H. Compton
    Alberto Papi
    Paul Jones
    Respiratory Research, 21
  • [43] Nonadherence to health promotion depending on chronic obstructive pulmonary disease severity
    Jeong, Hyunwoo
    Kim, Soo Hyun
    Choi, Seongmi
    Kim, Heejung
    HEART & LUNG, 2022, 55 : 1 - 10
  • [44] Is chronic obstructive pulmonary disease a risk factor for death in patients with community acquired pneumonia?
    Bonnesen, Barbara
    Egelund, Gertrud Baunbaek
    Jensen, Andreas Vestergaard
    Andersen, Stine
    Petersen, Pelle Trier
    Rohde, Gernot
    Ravn, Pernille
    INFECTIOUS DISEASES, 2019, 51 (05) : 340 - 347
  • [45] Erythrocytosis in a patient with chronic obstructive pulmonary disease
    Vicari, AM
    Ponzoni, M
    Alberetto, M
    Martani, C
    Pontiroli, AE
    Folli, F
    HAEMATOLOGICA, 1998, 83 (02) : 183 - 186
  • [46] The Pneumonia Severity Index as a Predictor of In-Hospital Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
    Hu, Guoping
    Zhou, Yumin
    Wu, Yankui
    Yu, Yan
    Liang, Weiqiang
    Ran, Pixin
    PLOS ONE, 2015, 10 (07):
  • [47] Exposure to occupational risk factors is associated with the severity and progression of chronic obstructive pulmonary disease
    Chen, Yao
    Peng, Cong
    Zhang, Hua
    Cai, Yu
    Yuan, Rui
    Song, Pingping
    Zhang, Chunling
    Yan, Yongjian
    MEDICINE, 2023, 102 (06)
  • [48] Diagnosis and treatment of smoking in patients with chronic obstructive pulmonary disease. ADEPOCLE study
    de Abajo Larriba, Ana Beatriz
    Diaz Rodriguez, Angel
    Gonzalez-Gallego, Javier
    Mendez Rodriguez, Enrique
    Alvarez Alvarez, Maria Jesus
    Capon Alvarez, Jessica
    Peleteiro Cobo, Beatriz
    Mahmoud Atoui, Omar
    de Abajo Olea, Serafin
    de Mandojana Hernandez, Juan Martinez
    NUTRICION HOSPITALARIA, 2016, 33 (04) : 954 - 961
  • [49] A Patient Charter for Chronic Obstructive Pulmonary Disease
    Hurst, John R.
    Winders, Tonya
    Worth, Heinrich
    Bhutani, Mohit
    Gruffydd-Jones, Kevin
    Stolz, Daiana
    Dransfield, Mark T.
    ADVANCES IN THERAPY, 2021, 38 (01) : 11 - 23
  • [50] Evaluation of Pregnancy-Associated Plasma Protein-A Levels in Patients with Chronic Obstructive Pulmonary Disease and Associations with Disease Severity
    Talay, Fahrettin
    Tosun, Mehmet
    Yasar, Zehra Asuk
    Kurt, Ozlem Kar
    Kargi, Aysel
    Ozturk, Serkan
    Ozlu, Mehmet Fatih
    Alcelik, Aytekin
    INFLAMMATION, 2016, 39 (03) : 1130 - 1133